| Characteristic . | Encephalitozoon Species . | P Value . | |
|---|---|---|---|
| . | Positive (n = 9) . | Negative (n = 14) . | . |
| Age, y, median (range) | 71 (61–89) | 70 (47–82) | .396 |
| Sex, No. (%) | |||
| Male | 0 (0) | 6 (42.9) | .048 |
| Female | 9 (100) | 8 (57.1) | .048 |
| Setting of residence, No. (%) | |||
| Industrial | 8 (88.9) | 8 (57.1) | .176 |
| Rural | 1 (11.1) | 6 (42.9) | .176 |
| Risk factors for periprosthetic joint infectiona, No. (%) | |||
| Diabetes mellitus | 1 (11.1) | 1 (7.1) | 1.000 |
| Rheumatoid arthritis | 1 (11.1) | 0 | .391 |
| Time after primary hip arthroplasty, y, median (range) | 14 (7–21) | 13 (5–19) | .277 |
| Characteristic . | Encephalitozoon Species . | P Value . | |
|---|---|---|---|
| . | Positive (n = 9) . | Negative (n = 14) . | . |
| Age, y, median (range) | 71 (61–89) | 70 (47–82) | .396 |
| Sex, No. (%) | |||
| Male | 0 (0) | 6 (42.9) | .048 |
| Female | 9 (100) | 8 (57.1) | .048 |
| Setting of residence, No. (%) | |||
| Industrial | 8 (88.9) | 8 (57.1) | .176 |
| Rural | 1 (11.1) | 6 (42.9) | .176 |
| Risk factors for periprosthetic joint infectiona, No. (%) | |||
| Diabetes mellitus | 1 (11.1) | 1 (7.1) | 1.000 |
| Rheumatoid arthritis | 1 (11.1) | 0 | .391 |
| Time after primary hip arthroplasty, y, median (range) | 14 (7–21) | 13 (5–19) | .277 |
aBecause no history of renal insufficiency or malignancy was identified in Encephalitozoon-positive patients after revision total hip arthroplasty, these risk factors are not specified.
| Characteristic . | Encephalitozoon Species . | P Value . | |
|---|---|---|---|
| . | Positive (n = 9) . | Negative (n = 14) . | . |
| Age, y, median (range) | 71 (61–89) | 70 (47–82) | .396 |
| Sex, No. (%) | |||
| Male | 0 (0) | 6 (42.9) | .048 |
| Female | 9 (100) | 8 (57.1) | .048 |
| Setting of residence, No. (%) | |||
| Industrial | 8 (88.9) | 8 (57.1) | .176 |
| Rural | 1 (11.1) | 6 (42.9) | .176 |
| Risk factors for periprosthetic joint infectiona, No. (%) | |||
| Diabetes mellitus | 1 (11.1) | 1 (7.1) | 1.000 |
| Rheumatoid arthritis | 1 (11.1) | 0 | .391 |
| Time after primary hip arthroplasty, y, median (range) | 14 (7–21) | 13 (5–19) | .277 |
| Characteristic . | Encephalitozoon Species . | P Value . | |
|---|---|---|---|
| . | Positive (n = 9) . | Negative (n = 14) . | . |
| Age, y, median (range) | 71 (61–89) | 70 (47–82) | .396 |
| Sex, No. (%) | |||
| Male | 0 (0) | 6 (42.9) | .048 |
| Female | 9 (100) | 8 (57.1) | .048 |
| Setting of residence, No. (%) | |||
| Industrial | 8 (88.9) | 8 (57.1) | .176 |
| Rural | 1 (11.1) | 6 (42.9) | .176 |
| Risk factors for periprosthetic joint infectiona, No. (%) | |||
| Diabetes mellitus | 1 (11.1) | 1 (7.1) | 1.000 |
| Rheumatoid arthritis | 1 (11.1) | 0 | .391 |
| Time after primary hip arthroplasty, y, median (range) | 14 (7–21) | 13 (5–19) | .277 |
aBecause no history of renal insufficiency or malignancy was identified in Encephalitozoon-positive patients after revision total hip arthroplasty, these risk factors are not specified.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
